Clinical Trials on Ovarian Serous Cystadenocarcinoma in United States

Total 36073 results

KU Leuven

Unknown

International Ovarian Tumour Analysis (IOTA) Phase 5 (IOTA-5)

Ovarian Cysts | Ovarian Tumors | Adnexal Masses

United States
Jonsson Comprehensive Cancer Center

Completed

A Open Label Study of the Efficacy and Safety of PD0332991 a Selective Inhibitor of the Cyclin Dependent Kinases 4 and 6 in Patients With Recurrent Ovarian Cancer Demonstrating Rb-proficiency and Low p16 Expression

Ovarian Epithelial Carcinoma

United States
Montefiore Medical Center
National Cancer Institute (NCI)

Completed

Ixabepilone in Treating Patients With Relapsed and/or Refractory Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer

Ovarian Cancer | Peritoneal Cavity Cancer

United States
National Cancer Institute (NCI)

Terminated

BMN 673 (Talazoparib), an Oral PARP Inhibitor, in People With Deleterious BRCA1/2 Mutation-Associated Ovarian Cancer Who Have Had Prior PARP Inhibitor Treatment

Ovarian Cancer

United States
M.D. Anderson Cancer Center

Completed

Mesenchymal Stem Cells (MSC) for Ovarian Cancer

Ovarian Cancer

United States
Dana-Farber Cancer Institute
Massachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham...

Completed

Young Women Diagnosed With Early Stage Ovarian Cancer: A Focus on Fertility Issues and Sexual Function

Ovarian Cancer

United States
University of Minnesota

Completed

Mobile Phone Technology to Increase Genetic Counseling (mAGIC)

Ovarian Cancer

United States
UConn Health
National Cancer Institute (NCI)

Terminated

Photoacoustic Imaging of the Ovary

Ovarian Cancer

United States
University of Alabama at Birmingham

Completed

Salpingectomy at Cesarean Delivery for Ovarian Cancer Reduction (SCORE) (SCORE)

Ovarian Cancer

United States
NYU Langone Health
OSI Pharmaceuticals

Terminated

Topotecan With Erlotinib for Topotecan Pretreated Ovarian Cancer

Ovarian Cancer

United States
M.D. Anderson Cancer Center

Completed

Elizabeth Registry for Low Grade Ovarian Cancer

Ovarian Cancer

United States
University of Arizona
Genentech, Inc.

Completed

Bevacizumab and Erlotinib Study in Advanced Ovarian Cancer

Ovarian Neoplasms

United States
NYU Langone Health

Terminated

NYU Ovarian Cancer Early Detection Program Blood and Genetics

Ovarian Cancer

United States
Duke University

Completed

Prospective Randomized Trial of Streamlined Genetic Education and Testing for Ovarian Cancer Patients

Fallopian Tube Cancer | Peritoneal Cancer | Ovarian Cancer, Epithelial

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

TAK-659 and Paclitaxel in Treating Patients With Advanced Solid Tumors

Advanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Ovarian Carcinoma | Refractory Ovarian Carcinoma

United States
University of Alabama at Birmingham
Novartis Pharmaceuticals

Completed

Phase IB Trial of LDE225 and Paclitaxel in Recurrent Ovarian Cancer

Recurrent Ovarian Cancer

United States
Roswell Park Cancer Institute
National Cancer Institute (NCI)

Withdrawn

Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Stage IIA Fallopian Tube Cancer | Stage IIA Ovarian Cancer | Stage IIB Fallopian Tube Cancer | Stage IIB Ovarian Cancer | Stage IIC Fallopian Tube Cancer | Stage IIC Ovarian Cancer | Stage IIIA Fallopian... and other conditions

United States
Splash Pharmaceuticals, Inc.

Unknown

Safety and Efficacy Study of Daily SPL-108 Injections In Conjunction With Paclitaxel in Women With Ovarian Cancer

Ovarian Epithelial Cancer

United States
Abramson Cancer Center of the University of Pennsylvania
Ovarian Cancer Research Center

Terminated

Autologous OC-L Vaccine and Ovarian Cancer

Fallopian Tube Cancer | Primary Peritoneal Cancer | Primary Ovarian Cancer

United States
Center for Human Reproduction

Recruiting

Ovarian Function Following Intraovarian Injection of PRP (PRP4POA)

Diminished Ovarian Reserve | Diminished Ovarian Reserve Due to Advanced Maternal Age

United States
National Cancer Institute (NCI)

Completed

Cisplatin and Flavopiridol in Treating Patients With Advanced Ovarian Epithelial Cancer or Primary Peritoneal Cancer

Stage IV Ovarian Epithelial Cancer | Recurrent Ovarian Epithelial Cancer | Recurrent Primary Peritoneal Cavity Cancer | Stage IV Primary Peritoneal Cavity Cancer | Stage IIIA Ovarian Epithelial Cancer | Stage IIIB Ovarian Epithelial Cancer | Stage IIIC Ovarian Epithelial Cancer | Stage IIIA Primary... and other conditions

United States
Georgetown University
United States Department of Defense

Suspended

A Combination Therapy Strategy to Prevent Anti-PD-1 Therapy Resistance in Metastatic Ovarian Cancer Patients

Ovarian Cancer Stage IV | Ovarian Cancer Stage III | Ovarian Cancer Stage 3

United States
Azaya Therapeutics, Inc.

Unknown

A Crossover Bioequivalence Study of Intravenously Administered ATI0918 and DOXIL/CAELYX in Patients With Ovarian Cancer

Cancer | Ovarian Cancer | Ovarian Epithelial Cancer Recurrent | Malignant Female Reproductive System Neoplasm | Ovarian Tumor

Canada, United States
University of Colorado, Denver
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Recruiting

Role of Semaglutide in Restoring Ovulation in Youth and Adults With Polycystic Ovary Syndrome (RESTORE)

Obese | PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries

United States
University of Washington

Completed

Genes Contributing to Hereditary Ovarian Cancer in Women and BRCA1/2 Wildtype Families

Ovarian Cancer

United States
NYU Langone Health

Completed

Feasibility of Multi-gene Panel Testing at the Time of Diagnosis for Patients With Ovarian Cancer

Ovarian Cancer

United States
Abramson Cancer Center of the University of Pennsylvania

Completed

WISER After Ovarian Cancer - Exercise Pilot Study

Ovarian Cancer

United States
Dana-Farber Cancer Institute
Patty Brisben Foundation For Women's Sexual Health

Completed

Sexual Therapy and Rehabilitation After Treatment for Ovarian Cancer (START-OC): A Pilot Intervention (START-OC)

Ovarian Cancer

United States
University of Washington

Completed

Fallopian Tube Removal as a Method of Ovarian Cancer Prevention: A Descriptive Study

Ovarian Cancer

United States
University of Arizona
Cephalon

Completed

Open Trial of Bendamustine Hydrochloride in Women With Advanced Ovarian Cancer

Ovarian Cancer

United States
University of Arizona
National Cancer Institute (NCI)

Completed

Effect of Flutamide on Biomarkers in Blood and Tissue Samples From Patients at High Risk of Ovarian Cancer

Ovarian Cancer

United States
University of Chicago

Completed

Tumor Gene Expression in Women With Ovarian Cancer

Ovarian Cancer

United States
Memorial Sloan Kettering Cancer Center

Completed

Motion Correction in Dynamic Contrast Enhanced Magnetic Resonance Imaging (MRI) in Ovarian Cancer: A Pilot Study

Ovarian Cancer

United States
Massachusetts General Hospital
National Cancer Institute (NCI)

Unknown

Clinical Trial to Screen Participants Who Are at High Genetic Risk for Ovarian Cancer

Ovarian Cancer

United States
Weill Medical College of Cornell University

Terminated

Weekly Topotecan Therapy in Patients With Ovarian Cancer

Ovarian Cancer

United States
Sidney Kimmel Cancer Center at Thomas Jefferson...

Completed

Carevive Survivor Care Planning System in Improving Quality of Life in Breast Cancer Survivors

Stage I Breast Cancer | Stage I Uterine Corpus Cancer | Stage II Uterine Corpus Cancer | Stage III Uterine Corpus Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage... and other conditions

United States
National Cancer Institute (NCI)

Completed

Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer

Uterine Carcinosarcoma | Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Uterine Corpus Carcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Endometrial Serous Adenocarcinoma | Lung Carcinoid Tumor | Metastatic... and other conditions

United States, Canada
Natera, Inc.

Terminated

Natera Ovarian Cancer Detection Assay

Adnexal Mass

United States
Memorial Sloan Kettering Cancer Center

Terminated

Sexual Functioning After Primary Treatment of Ovarian Cancer

Ovarian Cancer | Sexual Dysfunction

United States
M.D. Anderson Cancer Center
Celgene Corporation

Completed

Azacitidine and Valproic Acid Plus Carboplatin in Patients With Ovarian Cancer

Solid Tumors

United States
NYU Langone Health

Completed

Microvascular Ultrasonographic Imaging for the Detection of Early Stage Epithelial Ovarian Carcinoma

Ovarian Neoplasms

United States
National Cancer Institute (NCI)

Completed

Assessment of Screening Modalities for Gynecologic Cancers

Ovarian Cancer | Endometrial Cancer | Controls Without Endometrial Cancer | Controls Without Ovarian Cancer

United States
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer

Pseudomyxoma Peritonei | Recurrent Endometrial Carcinoma | Ovarian Sarcoma | Recurrent Uterine Sarcoma | Leydig Cell Tumor | Recurrent Ovarian Epithelial Cancer | Recurrent Primary Peritoneal Cavity Cancer | Ovarian Stromal Cancer | Recurrent Ovarian Germ Cell Tumor | Recurrent Fallopian Tube Cancer | Recurrent... and other conditions

United States
Aivita Biomedical, Inc.

Active, not recruiting

Autologous Dendritic Cells Loaded With Autologous Tumor Associated Antigens for Treatment of Advanced Epithelial Ovarian Carcinomas

Fallopian Tube Carcinoma | Primary Peritoneal Carcinoma | Stage III Ovarian Carcinoma | Stage IV Ovarian Carcinoma

United States
University of Utah

Withdrawn

Whole Abdomen Radiation in Conjunction With Intraperitoneal Chemotherapy for the Treatment of Small Volume Recurrent Ovarian Carcinoma Limited to the Peritoneal Cavity (WAR)

Recurrent Ovarian Carcinoma

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Dietary Magnesium in Preventing Low Blood Magnesium Levels in Patients With Ovarian Cancer Receiving Carboplatin Chemotherapy

Ovarian Carcinoma

United States
University of Oklahoma

Completed

Vitamin D, Leptin, Vitamin D Receptor Polymorphism, and Treatment-Related Morbidity in Ovarian Cancer

Ovarian Cancer

United States
Memorial Sloan Kettering Cancer Center

Completed

Benchmarking Intra-tumor Heterogeneity In Ovarian Cancer: Linking In-vivo Imaging Phenotypes With Histology And Genomics

Ovarian Cancer

United States
Jeanne Drisko, MD, CNS, FACN
University of Kansas Medical Center; Cancer Treatment Research Foundation

Completed

Treatment of Newly Diagnosed Ovarian Cancer With Antioxidants

Ovarian Cancer

United States
University of Iowa

Terminated

A Phase II Study of Interaction of Lovastatin and Paclitaxel For Patients With Refractory or Relapsed Ovarian Cancer

Ovarian Cancer

United States

Clinical Trials on Ovarian Serous Cystadenocarcinoma in United States

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kuwait

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations